LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.
- DOI
- 10.1016/s0140-6736(24)00821-3
- Published
- 2024 Jun 22
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-24-00821-3,
title = {LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.},
author = {Baumbach A and van Royen N and Amat-Santos IJ and Hudec M and Bunc M and Ijsselmuiden A and Laanmets P and Unic D and Merkely B and Hermanides RS and Ninios V and Protasiewicz M and Rensing BJWM and Martin PL and Feres F and De Sousa Almeida M and van Belle E and Linke A and Ielasi A and Montorfano M and Webster M and Toutouzas K and Teiger E and Bedogni F and Voskuil M and Pan M and Angerås O and Kim WK and Rothe J and Kristić I and Peral V and Garg S and Elzomor H and Tobe A and Morice MC and Onuma Y and Soliman O and Serruys PW and LANDMARK trial investigators},
year = {2024},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(24)00821-3},
url = {https://doi.org/10.1016/s0140-6736(24)00821-3}
}RIS
TY - JOUR TI - LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial. AU - Baumbach A AU - van Royen N AU - Amat-Santos IJ AU - Hudec M AU - Bunc M AU - Ijsselmuiden A AU - Laanmets P AU - Unic D AU - Merkely B AU - Hermanides RS AU - Ninios V AU - Protasiewicz M AU - Rensing BJWM AU - Martin PL AU - Feres F AU - De Sousa Almeida M AU - van Belle E AU - Linke A AU - Ielasi A AU - Montorfano M AU - Webster M AU - Toutouzas K AU - Teiger E AU - Bedogni F AU - Voskuil M AU - Pan M AU - Angerås O AU - Kim WK AU - Rothe J AU - Kristić I AU - Peral V AU - Garg S AU - Elzomor H AU - Tobe A AU - Morice MC AU - Onuma Y AU - Soliman O AU - Serruys PW AU - LANDMARK trial investigators PY - 2024 JO - Lancet (London, England) DO - 10.1016/s0140-6736(24)00821-3 UR - https://doi.org/10.1016/s0140-6736(24)00821-3 ER -
APA
A, B., N, V. R., IJ, A., M, H., M, B., A, I., P, L., D, U., B, M., RS, H., V, N., M, P., BJWM, R., PL, M., F, F., M, D. S. A., E, V. B., A, L., A, I., M, M., M, W., K, T., E, T., F, B., M, V., M, P., O, A., WK, K., J, R., I, K., V, P., S, G., H, E., A, T., MC, M., Y, O., O, S., PW, S., & investigators, L. T. (2024). LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(24)00821-3
Source records
- pubmed · retrieved 2026-09-25T20:11:55.540Z